ChiCTR2300073765 版本V1.0 版本创建时间2023/07/20 11:24:31 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300073765 

最近更新日期:

Date of Last Refreshed on:

2023-07-20 11:24:05 

注册时间:

Date of Registration:

2023-07-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

门诊患者结肠镜焦虑现况的调查和基于纽曼系统模式门诊结肠镜检查患者焦虑干预方案的构建

Public title:

An investigation of the current status of colonoscopy anxiety in outpatients and the construction of an anxiety intervention program for outpatients undergoing colonoscopy based on the Newman system model

注册题目简写:

English Acronym:

研究课题的正式科学名称:

门诊患者结肠镜焦虑现况的调查和基于纽曼系统模式门诊结肠镜检查患者焦虑干预方案的构建

Scientific title:

An investigation of the current status of colonoscopy anxiety in outpatients and the construction of an anxiety intervention program for outpatients undergoing colonoscopy based on the Newman system model

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

曾颖 

研究负责人:

乐倩倩 

Applicant:

Ying zeng 

Study leader:

Qianqian Yue 

申请注册联系人电话:

Applicant telephone:

+86 177 7348 6339

研究负责人电话:

Study leader's telephone:

+86 158 7236 5102

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zengying2003@126.com

研究负责人电子邮件:

Study leader's E-mail:

1835301002@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖南省衡阳市蒸湘区常胜西路28号

研究负责人通讯地址:

湖南省衡阳市蒸湘区常胜西路28号

Applicant address:

28 West Changsheng Road, Hengyang, Hunan

Study leader's address:

28 West Changsheng Road, Hengyang, Hunan

申请注册联系人邮政编码:

Applicant postcode:

421001

研究负责人邮政编码:

Study leader's postcode:

421001

申请人所在单位:

湖南省衡阳市南华大学护理学院

Applicant's institution:

School of Nursing, University of South China, Hengyang, Hunan

研究负责人所在单位:

湖南省衡阳市南华大学护理学院

Affiliation of the Leader:

School of nursing University of South China

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022-USC-HL-226

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南华大学医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee University of south china

伦理委员会批准日期:

Date of approved by ethic committee:

2022-11-10 00:00:00

伦理委员会联系人:

刘良专

Contact Name of the ethic committee:

Liangzhuan Liu

伦理委员会联系地址:

湖南省衡阳市蒸湘区常胜西路28号

Contact Address of the ethic committee:

28 West Changsheng Road, Hengyang, Hunan

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 734 828 2726

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南华大学护理学院

Primary sponsor:

School of nursing University of South China

研究实施负责(组长)单位地址:

湖南省衡阳市蒸湘区常胜西路28号

Primary sponsor's address:

28 West Changsheng Road, Hengyang, Hunan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南

市(区县):

衡阳

Country:

China

Province:

Hunan

City:

Hengyang

单位(医院):

南华大学附属第一医院

具体地址:

南华大学附属第一医院位于湖南省衡阳市船山路69号

Institution
hospital:

The First Affiliated Hospital of Nanhua University

Address:

The First Affiliated Hospital of Nanhua University is located at No. 69, Funshan Road, Hengyang City, Hunan Province, China.

经费或物资来源:

湖南省教育厅优秀青年项目,资助/奖励编号:19B495

Source(s) of funding:

Excellent Youth Project of Hunan Provincial Department of Education, Grant/Award number: 19B495

Target disease:

Anxiety in patients undergoing colonoscopy

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探究心理干预对结肠镜检查患者焦虑的影响  

Objectives of Study:

Exploring the effects of psychological interventions on anxiety in patients undergoing colonoscopy

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)人群:年龄≥18 岁,有独立思考能力,首次参与结肠镜检查的患者; (2)意识清楚,可以有效沟通者,不选择使用镇静药物; (3)签署知情同意书,并且自愿参加本研究。

Inclusion criteria

(1) Population: patients ≥18 years of age, capable of independent thought, and participating in colonoscopy for the first time; (2) Those who are conscious, can communicate effectively, and do not choose to use sedative drugs; (3) Signed informed consent and voluntarily participated in this study.

排除标准:

(1)明确诊断为结直肠癌; (2)有精神障碍、老年痴呆等。

Exclusion criteria:

(1) Clear diagnosis of colorectal cancer; (2) Have mental disorders, dementia, etc.

研究实施时间:

Study execute time:

From 2023-08-01 00:00:00 To 2023-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-08-01 00:00:00 To 2023-11-30 00:00:00  

干预措施:

Interventions:

组别:

干预组

样本量:

40

Group:

intervention group

Sample size:

干预措施:

将事先准备好的结肠镜检查相关知识手册,向患者讲解结肠镜检查的一整个过程,同时给患者看预先准备好的结肠镜操作过程中的视频,讲解过程中嘱患者做好心理准备,此阶段为10分钟。讲解后询问患者内心感受,耐心倾听患者主诉,随后对患者不正确的认知进行纠正,并对患者进行鼓励、安慰,例举治疗情况类似的案例,帮助患者增加信心,教会患者深呼吸,在术中同样适用,同时指导患者自我鼓励,时间控制在10-15分钟。 指导患者想象做结肠镜的过程,想象自己从检查室至治疗完成过程中可能出现的不良心理情绪以及不适反应,鼓励、引导患者说出内心感受,引导患者宣泄不良心理情绪,指导患者采取有效措施预防不适,时间控制在10-15分钟。随后对过程进行总结和疏导,根据患者具体情况在再开展针对性的健康教育。

干预措施代码:

Intervention:

The pre-prepared knowledge manual of colonoscopy, explain the whole colonoscopy process to the patient and show the pre-prepared video of the colonoscopy operation to the patient, and ask the patient to be psychologically prepared during the explanation. This stage is 10 minutes. After the explanation, ask the patient about his inner feelings, listen patiently to the patient's complaints, then correct the patient's incorrect perceptions, encourage and comfort the patient, citing cases with similar treatment situations, help the patient increase his confidence, teach the patient to breathe deeply, which is also applicable during the operation, and instruct the patient to encourage himself, the time is limited to 10-15 minutes. Instruct patients to imagine the process of colonoscopy, imagine their possible adverse psychological emotions and discomfort reactions during the process from the examination room to the completion of treatment, encourage and guide patients to tell their inner feelings, guide them to vent their adverse psychological emotions, instruct them to take effective measures to prevent discomfort, and control the time to 10-15 minutes.

Intervention code:

组别:

对照组

样本量:

40

Group:

control group

Sample size:

干预措施:

常规护理,在结肠镜预约的同时发放肠道准备的小册子,术后给予进食指导(一般情况术后半小时可以进食,食清淡易消化的食物)。

干预措施代码:

Intervention:

Routine care was provided, pamphlets on bowel preparation were distributed along with colonoscopy appointments, and postoperative instructions on eating were given (usually you can eat half an hour after the procedure, with light, easily digestible food).

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖南 

市(区县):

衡阳 

Country:

China 

Province:

Hunan 

City:

Hengyang 

单位(医院):

南华大学附属第一医院  

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of University of South China

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

焦虑

指标类型:

主要指标

Outcome:

anxiety

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛

指标类型:

主要指标

Outcome:

pain

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肠道准备情况

指标类型:

主要指标

Outcome:

Bowel preparation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

次要指标

Outcome:

pulse rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

次要指标

Outcome:

hypertension

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

符合条件的参与者被随机分配到干预组(I)或对照组(C)。在整个受试者招募期间,采用了区块大小为8的分块随机化,以保持两组参与者的良好平衡。基于计算机生成的随机代码的顺序组(I或C)是事先准备好的,并由独立于研究的人装入连续编号的不透明密封信封。对于每个完成基线数据收集的同意参与者,信封被依次打开。在这项研究中,作为结果评估者的研究助理对分配顺序是盲的。

Randomization Procedure (please state who generates the random number sequence and by what method):

Eligible participants were randomly allocated to either intervention group (I) or control group (C). Blocked randomization with a block size of eight was used to maintain a good balance of participants between the two groups throughout the subject recruitment period. Asequence group (I or C) based on computer-generated random codes was prepared in advance and put in serially numbered opaque sealed envelope by a person independent to the study. The envelope was opened sequentially for each consented participant who had completed the baseline data collection. In this study, a research assistant who served as outcome assessor was blinded to the allocation sequence.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

由于心理教育干预所需的条件,不可能对干预人员实行盲法。所有基线信息和临床访谈都是在随机化之前收集和进行的。数据的管理将由被实施盲法的工作人员完成。对结果的统计分析和由此得出的结论也将是盲目的。试验结果将由独立的统计学家进行分析,研究小组将对结果进行解释。

Blinding:

Due to the conditions required for psychoeducational interventions, it is not possible to blind the interventionists. Baseline information and clinical interviews are gathered and conducted prior to randomization. Management of the data will be done by the staff member being blinded. Statistical analysis of the results and resulting conclusions will also be blinded. The trial results will be analyzed by an independent statistician, and the results will be interpreted by the research team.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2024年6月1日,临床试验公共管理平台,http://www.medresman.org

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

June 1, 2024, ResMan, a public management platform for clinical trials, http://www.medresman.org

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表和电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form and Electronic Data Capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-07-20 11:24:05